DEF14A

Company

Bionano Genomics, Inc.

Filed

August 21, 2024

Period of Report

October 2, 2024

Accession Number

0001140361-24-038087

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →